InMed Pharmaceuticals Inc.

Ownership Transactions Reported by 17 Insiders

Symbol: INM on Nasdaq
Industry: Pharmaceutical Preparations
Location: 1445 885 West Georgia St., Vancouver, British Columbia, Canada

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	1	-240	100%	$0.18	-$42
Net	-1	-240	-100%		-$42

Showing 1 to 3 of 3 entries

InMed Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Eric A. Adams	President & CEO, Director	$15.8K			Dec 20, 2024
Andrew Hull	Director	$14.9K			Jan 11, 2025
Bruce Colwill	Cfo	$10.3K			Jan 24, 2022
Alexandra Diane Janet Mancini	Consultant	$0	-$42	-100%	Jul 31, 2024
Eric C. Hsu	Sr. VP, Pre-Clinical Res/Dev				Dec 20, 2024
Michael Woudenberg	Chief Operating Officer				Dec 20, 2024
Shane Johnson	Sr VP & General Manager				Dec 20, 2024
Catherine Sazdanoff	Director				Dec 29, 2021
Sarah Li	VP Accounting & Controller				Dec 16, 2022
Jonathan Tegge	Interim CFO				Dec 23, 2023
Nicole Lemerond	Director				Dec 20, 2024
Janet Grove	Director				Dec 20, 2024
Brenda Edwards	Interim CFO				Apr 1, 2022
Bryan Baldasare	Director				Dec 20, 2024
William J. Garner	Director				Jan 24, 2022
Adam D. Cutler	Director				Jan 24, 2022
Netta Jagpal	Chief Financial Officer				Dec 20, 2024

Recent Insider Transactions by Companies or Individuals for InMed Pharmaceuticals Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.